Contribution of GABA(A) receptors containing α3 subunits to the therapeutic-related and side effects of benzodiazepine-type drugs in monkeys
- PMID: 21190016
- PMCID: PMC3097109
- DOI: 10.1007/s00213-010-2142-y
Contribution of GABA(A) receptors containing α3 subunits to the therapeutic-related and side effects of benzodiazepine-type drugs in monkeys
Abstract
Rationale: Experimental evidence suggests that the differential behavioral effects of benzodiazepines depend on their relative actions at γ-aminobutyric acid type A (GABA(A)) receptors that contain either an α1, α2, α3, or α5 subunit.
Objectives: The present study was aimed at understanding the role of α3 subunit-containing GABA(A) (α3GABA(A)) receptors by examining the behavioral pharmacology of TP003 (4,2'-difluoro-5'-[8-fluoro-7-(1-hydroxy-1-methylethyl)imidazo[1,2-a]pyridine-3-yl]biphenyl-2-carbonitrile), which shows functional selectivity for α3GABA(A) receptors.
Methods: First, a conflict procedure was used to assess the anxiolytic-like effects of TP003 and a representative clinically available benzodiazepine. TP003 was also administered before daily periods of sucrose pellet availability to evaluate potential hyperphagic effects. In separate experiments, observable behavioral effects were used to assess the motor and sedative effects of TP003.
Results: Administration of TP003 produced robust anti-conflict effects without the rate-decreasing effects that were observed with the representative benzodiazepine. Unlike the reported effects of benzodiazepines, TP003 did not enhance palatable food consumption. However, increases in observable sleep-associated posture were induced by TP003, as were decreases in some species-typical behaviors (vocalization, locomotion, and environment-directed behaviors). When evaluated for its ability to induce a procumbent posture, TP003 failed to produce an effect.
Conclusions: Based on conflict and observation tests in monkeys, our results suggest that TP003 may have anxiolytic properties but lack ataxic, hyperphagic, and pronounced sedative effects characteristic of classical benzodiazepines. TP003 did induce myorelaxant-like effects and had relatively mild sedative effects. Collectively, these results suggest that α3GABA(A) receptors play an important role in the anxiolytic-like and motor effects of benzodiazepine-type drugs.
Figures



Similar articles
-
The behavioral pharmacology of zolpidem: evidence for the functional significance of α1-containing GABA(A) receptors.Psychopharmacology (Berl). 2014 May;231(9):1865-96. doi: 10.1007/s00213-014-3457-x. Epub 2014 Feb 22. Psychopharmacology (Berl). 2014. PMID: 24563183 Review.
-
Evidence That Sedative Effects of Benzodiazepines Involve Unexpected GABAA Receptor Subtypes: Quantitative Observation Studies in Rhesus Monkeys.J Pharmacol Exp Ther. 2018 Jul;366(1):145-157. doi: 10.1124/jpet.118.249250. Epub 2018 May 2. J Pharmacol Exp Ther. 2018. PMID: 29720564 Free PMC article.
-
Enhanced sucrose pellet consumption induced by benzodiazepine-type drugs in squirrel monkeys: role of GABAA receptor subtypes.Psychopharmacology (Berl). 2006 Aug;187(3):321-30. doi: 10.1007/s00213-006-0431-2. Epub 2006 Jun 17. Psychopharmacology (Berl). 2006. PMID: 16783540
-
Selective antagonism of the ataxic effects of zolpidem and triazolam by the GABAA/alpha1-preferring antagonist beta-CCt in squirrel monkeys.Psychopharmacology (Berl). 2002 Nov;164(2):151-9. doi: 10.1007/s00213-002-1189-9. Epub 2002 Sep 4. Psychopharmacology (Berl). 2002. PMID: 12404077
-
GABAA receptor subtype-selective modulators. I. α2/α3-selective agonists as non-sedating anxiolytics.Curr Top Med Chem. 2011;11(9):1176-202. doi: 10.2174/156802611795371350. Curr Top Med Chem. 2011. PMID: 21050172 Review.
Cited by
-
The behavioral pharmacology of zolpidem: evidence for the functional significance of α1-containing GABA(A) receptors.Psychopharmacology (Berl). 2014 May;231(9):1865-96. doi: 10.1007/s00213-014-3457-x. Epub 2014 Feb 22. Psychopharmacology (Berl). 2014. PMID: 24563183 Review.
-
Pharmacological and antihyperalgesic properties of the novel α2/3 preferring GABAA receptor ligand MP-III-024.Brain Res Bull. 2017 May;131:62-69. doi: 10.1016/j.brainresbull.2017.03.001. Epub 2017 Mar 4. Brain Res Bull. 2017. PMID: 28267561 Free PMC article.
-
Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes.Nat Rev Drug Discov. 2011 Jul 29;10(9):685-97. doi: 10.1038/nrd3502. Nat Rev Drug Discov. 2011. PMID: 21799515 Free PMC article. Review.
-
Evidence That Sedative Effects of Benzodiazepines Involve Unexpected GABAA Receptor Subtypes: Quantitative Observation Studies in Rhesus Monkeys.J Pharmacol Exp Ther. 2018 Jul;366(1):145-157. doi: 10.1124/jpet.118.249250. Epub 2018 May 2. J Pharmacol Exp Ther. 2018. PMID: 29720564 Free PMC article.
-
GABAA Receptor Subtypes and the Abuse-Related Effects of Ethanol in Rhesus Monkeys: Experiments with Selective Positive Allosteric Modulators.Alcohol Clin Exp Res. 2019 May;43(5):791-802. doi: 10.1111/acer.14000. Epub 2019 Apr 8. Alcohol Clin Exp Res. 2019. PMID: 30861153 Free PMC article.
References
-
- Atack JR, Wafford KA, Tye SJ, Cook SM, Sohal B, Pike A, Sur C, Melillo D, Bristow L, Bromidge F, Ragan I, Kerby J, Street L, Carling R, Castro JL, Whiting P, Dawson GR, McKernan RM. TPA023 [7-(1,1-Dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-30ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine], an agonist selective for α2 and α3-containing GABAA receptors, is a nonsedating anxiolytic in rodents and primates. J Pharmacol Exp Ther. 2006;316:410–422. - PubMed
-
- Collinson N, Kuenzi FM, Jarolimek W, Maubach KA, Cothliff R, Sur C, Smith A, Otu FM, Howell O, Atack JR, McKernan RM, Seabrook GR, Dawson GR, Whiting PJ, Rosahl TW. Enhanced learning and memory and altered GABAergic synaptic transmission in mice lacking the alpha 5 subunit of the GABAA receptor. J Neurosci. 2002;22:5572–5580. - PMC - PubMed
-
- Cooper SJ, Estall LB. Behavioural pharmacology of food, water and salt intake in relation to drug actions at benzodiazepine receptors. Neurosci Biobehav Rev. 1985;9:5–19. - PubMed
-
- Cooper SJ, Ridley ET. Abecarnil and palatability: taste reactivity in normal ingestion in male rats. Pharmacol Biochem Behav. 2005;81:517–523. - PubMed
-
- Crestani F, Löw K, Keist R, Mandelli M, Möhler H, Rudolph U. Molecular targets for the myorelaxant action of diazepam. Mol Pharmacol. 2001;59:442–445. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources